Next Article in Journal
A Phase 1, Randomized, Double-Blinded, Placebo-Controlled and Dose-Escalation Study to Evaluate the Safety and Immunogenicity of the Intranasal DelNS1-nCoV-RBD LAIV for COVID-19 in Healthy Adults
Next Article in Special Issue
Examining the Negative Sentiments Related to Influenza Vaccination from 2017 to 2022: An Unsupervised Deep Learning Analysis of 261,613 Twitter Posts
Previous Article in Journal
Effect of the COVID-19 Pandemic on Paediatric Check-Ups and Vaccinations in Germany
Previous Article in Special Issue
A Scoping Review of Three Dimensions for Long-Term COVID-19 Vaccination Models: Hybrid Immunity, Individual Drivers of Vaccinal Choice, and Human Errors
 
 
Article

Article Versions Notes

Vaccines 2023, 11(4), 721; https://doi.org/10.3390/vaccines11040721
Action Date Notes Link
article pdf uploaded. 23 March 2023 16:36 CET Version of Record https://www.mdpi.com/2076-393X/11/4/721/pdf-vor
article supplementary file uploaded. 23 March 2023 16:36 CET - https://www.mdpi.com/2076-393X/11/4/721#supplementary
article xml uploaded. 24 March 2023 03:33 CET Original file https://www.mdpi.com/2076-393X/11/4/721/xml
article pdf uploaded. 24 March 2023 03:33 CET Updated version of record https://www.mdpi.com/2076-393X/11/4/721/pdf
article html file updated 24 March 2023 03:34 CET Original file -
article html file updated 6 April 2023 22:05 CEST Update https://www.mdpi.com/2076-393X/11/4/721/html
Back to TopTop